Estrogen Replacement TherapyEstrogens, Conjugated (USP)Hormone Replacement TherapyProgestinsMedroxyprogesterone AcetatePostmenopauseMenopauseHormonesEstrogensNorpregnenesMedroxyprogesteroneThyroid HormonesFollicle Stimulating HormoneHuman Growth HormoneGonadal Steroid HormonesHot FlashesLuteinizing HormoneBreast NeoplasmsGonadotropin-Releasing HormoneProgesterone CongenersAntineoplastic Agents, HormonalParathyroid HormoneEstradiolEurope, EasternWomen's HealthAndrogen AntagonistsOvariectomyProgesteroneReceptors, Thyroid HormoneEstradiol CongenersRisk FactorsAdrenocorticotropic HormoneNorethindroneMammographyNeoplasms, Hormone-DependentProstatic NeoplasmsPituitary HormonesGynecologyQuinestrolTestosteroneHysterectomyTamoxifenEstoniaGoserelinSelective Estrogen Receptor ModulatorsEstroneMastodyniaReceptors, EstrogenTriiodothyronineReceptors, ProgesteroneRandomized Controlled Trials as TopicThyrotropinThyroxineLeuprolideJuvenile HormonesFlutamideFollow-Up StudiesEstrogen Receptor ModulatorsOrchiectomyPerimenopauseClimactericAndrostenesGrowth DisordersTurner SyndromeDouble-Blind MethodDydrogesteroneGrowth Hormone-Releasing HormoneTosyl CompoundsAdministration, CutaneousTime FactorsMetrorrhagiaBreastAromatase InhibitorsProspective StudiesEstrogen Receptor alphaCase-Control StudiesCorticotropin-Releasing HormoneAndrogensIncidenceDrug Therapy, CombinationHypothalamic HormonesPeptide HormonesEndometrial NeoplasmsPituitary GlandCohort StudiesMacaca fascicularisLentinulaAge FactorsAnti-Mullerian HormoneGonadal HormonesProportional Hazards ModelsThyroid Hormone Receptors betaCarcinoma, LobularRiskTreatment OutcomeProlactinPrepaid Health PlansNitrilesEstrogen AntagonistsMegestrol Acetate